Contingency Management for Smoking Cessation

Ukraine site, Kiev, Ukraine
Smoking CessationContingency Management - Behavioral
All Sexes

Study Summary

This trial tests a new way to help people stick to a smoking cessation program. The treatment offers subjects the chance to forego a monetary incentive in exchange for abstaining from smoking.

Treatment Effectiveness

Study Objectives

3 Primary · 4 Secondary · Reporting Duration: 14 days following intake date, as well as 1 month and 6 months after intake date

Day 14
Breath Carbon Monoxide Test (measured in ppm levels)
Contingency Management Payment
Maximum number of consecutive abstinent days
Proportion of CO (CO ≤ 4ppm)
Time to first relapse
Month 6
Reduced smoking

Trial Safety

Trial Design

2 Treatment Groups

Contingency Management
1 of 2
1 of 2

Experimental Treatment

Non-Treatment Group

200 Total Participants · 2 Treatment Groups

Primary Treatment: Contingency Management · Has Placebo Group · N/A

Contingency Management
Experimental Group · 1 Intervention: Contingency Management · Intervention Types: Behavioral
PlaceboComparator Group · 1 Intervention: Control · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
Completed Phase 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 14 days following intake date, as well as 1 month and 6 months after intake date

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,728 Previous Clinical Trials
20,525,418 Total Patients Enrolled
Ian Ayres, PhDPrincipal InvestigatorYale Law School
Giuseppe Mattiacci, PhDPrincipal InvestigatorUniversity of Amsterdam

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You smoke at least three cigarettes per week and want to stop smoking.

Frequently Asked Questions

Are there any opportunities available to join this research initiative?

"Data from confirms that this medical study is currently accepting patients, with the initial posting having taken place on October 13th 2021 and a subsequent edit made not long ago (October 7th 2022)." - Anonymous Online Contributor

Unverified Answer

What is the primary objective of this clinical investigation?

"The primary purpose of this trial, estimated to last 14 days from the intake date, is to measure Breath Carbon Monoxide Test (ppm levels). Secondary objectives include Reduced Smoking - quantified by reported changes in smoking habits; Contingency Management Payments - evaluated via total abstention rewards administered; and Time to First Relapse – documented through self-reported use of nicotine products or cigarette alternatives." - Anonymous Online Contributor

Unverified Answer

How many individuals are currently participating in this clinical experiment?

"Affirmative, data shows that this trial is actively searching for participants. It was first posted on October 13th 2021 and last updated on October 7th 2022, with a goal of recruiting 200 people from one particular location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.